Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration. Annals of the rheumatic diseases. 2018;77(9):1276-82.
28/02/2022
Lauper K, Nordström DC, Pavelka K, Hernández MV, Kvien TK, Kristianslund EK, et al.
Epub 2018/05/08. doi: 10.1136/annrheumdis-2017-212845. PubMed PMID: 29730637.